A carregar...
Can pimavanserin help patients with Parkinson disease psychosis?
Pimavanserin is a first-in-class selective serotonin 5-HT(2A) receptor inverse agonist approved for the treatment of Parkinson disease psychosis. This article discusses pimavanserin’s mechanism of action, which patients are appropriate candidates for therapy, adverse reactions, and appropriate dosin...
Na minha lista:
| Publicado no: | JAAPA |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764088/ https://ncbi.nlm.nih.gov/pubmed/30589736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.JAA.0000547757.46299.3d |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|